158 related articles for article (PubMed ID: 11163671)
1. Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test.
Rosskopf-Streicher U; Johannes S; Wilhelm M; Cussler K
Vaccine; 2001 Jan; 19(11-12):1477-83. PubMed ID: 11163671
[TBL] [Abstract][Full Text] [Related]
2. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
[TBL] [Abstract][Full Text] [Related]
3. General information about the validation of serological method (ELISA) for the batch potency testing erysipelas vaccines.
Altern Lab Anim; 2002; 30(5):486-7. PubMed ID: 12434771
[No Abstract] [Full Text] [Related]
4. Potency Testing of Swine Erysipelas Vaccines by Serology Results of a Pre-validation Study.
Rosskopf-Streicher U; Johannes S; Wilhelm M; Gyra H; Cussler K
ALTEX; 1999; 16(3):123-128. PubMed ID: 11107318
[TBL] [Abstract][Full Text] [Related]
5. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
Rosskopf-Streicher U; Johannes S; Gyra H; Beckmann R; Cussler K
Dev Biol (Basel); 2002; 111():153-8. PubMed ID: 12678235
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
[TBL] [Abstract][Full Text] [Related]
7. Towards in vitro potency testing of inactivated erysipelas vaccines.
Balks E; Wolf C; Loessner H; Werner E
Dev Biol (Basel); 2012; 134():37-44. PubMed ID: 22888593
[TBL] [Abstract][Full Text] [Related]
8. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
[TBL] [Abstract][Full Text] [Related]
9. [100 years of erysipelas prophylaxis: significance and reduction of animal experiments].
Cussler K; Balks E
ALTEX; 2001; 18(1):29-33. PubMed ID: 11248847
[TBL] [Abstract][Full Text] [Related]
10. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
Winsnes R; Sesardic D; Daas A; Behr-Gross ME
Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
[TBL] [Abstract][Full Text] [Related]
11. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
[TBL] [Abstract][Full Text] [Related]
12. Development of an enzyme-linked immunosorbent assay for the serological detection of exposure of poultry in New Zealand to Erysipelothrix rhusiopathiae and their serological response to vaccination.
Kurian A; Neumann EJ; Hall WF; Christensen N
N Z Vet J; 2012 Mar; 60(2):100-5. PubMed ID: 22352927
[TBL] [Abstract][Full Text] [Related]
13. Validation study to evaluate the reproducibility of a candidate in vitro potency assay of newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation.
Claassen I; Maas R; Oei H; Daas A; Milne C
Pharmeuropa Bio; 2004 Dec; 2004(1):1-15. PubMed ID: 15659281
[TBL] [Abstract][Full Text] [Related]
14. Induction of cross-protection in mice against dolphin Erysipelothrix rhusiopathiae isolates with a swine commercial vaccine.
Lacave G; Cox E; Hermans J; Devriese L; Goddeeris BM
Vet Microbiol; 2001 Jun; 80(3):247-53. PubMed ID: 11337140
[TBL] [Abstract][Full Text] [Related]
15. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
[TBL] [Abstract][Full Text] [Related]
16. Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use.
Daas A; Milne C
Pharmeuropa Bio; 2004 Dec; 2004(1):17-22. PubMed ID: 15659282
[TBL] [Abstract][Full Text] [Related]
17. Response of growth agglutinating antibody and protection of pigs inoculated with swine erysipelas live vaccine.
Sawada T; Muramatsu M; Seto K
Nihon Juigaku Zasshi; 1979 Dec; 41(6):593-600. PubMed ID: 522336
[No Abstract] [Full Text] [Related]
18. Effect of antibiotics on the immune system of animals. III. Experiments in pgis immunized with live and inactivated swine erysipelas vaccines.
Tu TD
Acta Vet Acad Sci Hung; 1981; 28(3):317-31. PubMed ID: 7258020
[No Abstract] [Full Text] [Related]
19. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.
von Hunolstein C; Gomez Miguel MJ; Pezzella C; Scopetti F; Behr-Gross ME; Halder M; Hoffmann S; Levels L; van der Gun J; Hendriksen C
Pharmeuropa Bio; 2008 Dec; 2008(1):7-18. PubMed ID: 19220977
[TBL] [Abstract][Full Text] [Related]
20. [Aerogenic immunization against swine erysipelas with Spirovak erysipelas vaccine "Dessau"].
Urbaneck D; Stöhr P; Michael-Meese M
Arch Exp Veterinarmed; 1980; 34(1):51-4. PubMed ID: 7416893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
